Reference:
Ahmad A, Yang W, Chen G, Shafiq M, Javed S, Ali Zaidi SS, et al. (2019) Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals. PLoS One. 14 (12): e0226372. doi:10.1371/journal.pone.0226372.
Al-Rubeaan K. (2015) National surveillance for type 1, type 2 diabetes and prediabetes among children and adolescents: a population-based study (SAUDI-DM). J Epidemiol Community Health. 69 (11): 1045-1051. doi:10.1136/jech-2015-205710.
Beale EG. (2013) Insulin signaling and insulin resistance. J Investig Med. 61 (1): 11-14. doi:10.2310/JIM.0b013e3182746f95.
Becker J, Gießelmann G, Hoffmann SL, Wittmann C. (2018) Corynebacterium glutamicum for Sustainable Bioproduction: From Metabolic Physiology to Systems Metabolic Engineering. Adv Biochem Eng Biotechnol. 162 217-263. doi:10.1007/10_2016_21.
Bergeron V, Ghislain J, Vivot K, Tamarina N, Philipson LH, Fielitz J, et al. (2018) Deletion of Protein Kinase D1 in Pancreatic β-Cells Impairs Insulin Secretion in High-Fat Diet-Fed Mice. Diabetes. 67 (1): 71-77. doi:10.2337/db17-0982.
Bhatti AA, Haq S, Bhat RA. (2017) Actinomycetes benefaction role in soil and plant health. Microb Pathog. 111 458-467. doi:10.1016/j.micpath.2017.09.036.
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 56 (7): 1761-1772. doi:10.2337/db06-1491.
Edgerton DS, Lautz M, Scott M, Everett CA, Stettler KM, Neal DW, et al. (2006) Insulin’s direct effects on the liver dominate the control of hepatic glucose production. J Clin Invest. 116 (2): 521-527. doi:10.1172/JCI27073.
Federico A, Dallio M, R DIS, Giorgio V, Miele L. (2017) Gut microbiota, obesity and metabolic disorders. Minerva Gastroenterol Dietol. 63 (4): 337-344. doi:10.23736/S1121-421X.17.02376-5.
Fugmann M, Breier M, Rottenkolber M, Banning F, Ferrari U, Sacco V, et al. (2015) The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes. Sci Rep. 5 13212. doi:10.1038/srep13212.
Jayachandran M, Xiao J, Xu B. (2017) A Critical Review on Health Promoting Benefits of Edible Mushrooms through Gut Microbiota. Int J Mol Sci. 18 (9): 1934. doi:10.3390/ijms18091934.
Jiang Y, Liu J, Zhou Z, Liu K, Liu C. (2018) Diosmetin Attenuates Akt Signaling Pathway by Modulating Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB)/Inducible Nitric Oxide Synthase (iNOS) in Streptozotocin (STZ)-Induced Diabetic Nephropathy Mice. Med Sci Monit. 24 7007-7014. doi:10.12659/MSM.910764.
Kattan W, Wan TTH. (2018) Factors Influencing Variations in Hospitalization for Diabetes with Hypoglycemia. J Clin Med. 7 (10): 367. doi:10.3390/jcm7100367.
Lange K, Buerger M, Stallmach A, Bruns T. (2016) Effects of Antibiotics on Gut Microbiota. Dig Dis. 34 (3): 260-268. doi:10.1159/000443360.
Lee JY, Na YA, Kim E, Lee HS, Kim P. (2016) The Actinobacterium Corynebacterium glutamicum, an Industrial Workhorse. J Microbiol Biotechnol. 26 (5): 807-822. doi:10.4014/jmb.1601.01053.
Muñoz-Garach A, Diaz-Perdigones C, Tinahones FJ. (2016) Gut microbiota and type 2 diabetes mellitus. Endocrinol Nutr. 63 (10): 560-568. doi:10.1016/j.endonu.2016.07.008.
Niswender KD. (2011) Basal insulin: physiology, pharmacology, and clinical implications. Postgrad Med. 123 (4): 17-26. doi:10.3810/pgm.2011.07.2300.
Petersen MC, Vatner DF, Shulman GI. (2017) Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol. 13 (10): 572-587. doi:10.1038/nrendo.2017.80.
Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 490 (7418): 55-60. doi:10.1038/nature11450.
Sabatino A, Regolisti G, Cosola C, Gesualdo L, Fiaccadori E. (2017) Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease. Curr Diab Rep. 17 (3): 16. doi:10.1007/s11892-017-0841-z.
Saito S, Oishi S, Shudo A, Sugiura Y, Yasunaga K. (2019) Glucose Response during the Night Is Suppressed by Wheat Albumin in Healthy Participants: A Randomized Controlled Trial. Nutrients. 11 (1): 187. doi:10.3390/nu11010187.
Seibold G, Dempf S, Schreiner J, Eikmanns BJ. (2007) Glycogen formation in Corynebacterium glutamicum and role of ADP-glucose pyrophosphorylase. Microbiology (Reading). 153 (Pt 4): 1275-1285. doi:10.1099/mic.0.2006/003368-0.
Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA. (2011) Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology. 140 (3): 976-986. doi:10.1053/j.gastro.2010.11.049.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444 (7122): 1027-1031. doi:10.1038/nature05414.
Tzeng TF, Lu HJ, Liou SS, Chang CJ, Liu IM. (2012) Emodin, a Naturally Occurring Anthraquinone Derivative, Ameliorates Dyslipidemia by Activating AMP-Activated Protein Kinase in High-Fat-Diet-Fed Rats. Evid Based Complement Alternat Med. 2012 781812. doi:10.1155/2012/781812.
van Bommel EJM, Herrema H, Davids M, Kramer MHH, Nieuwdorp M, van Raalte DH. (2020) Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes. Diabetes Metab. 46 (2): 164-168. doi:10.1016/j.diabet.2019.11.005.
Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, et al. (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 328 (5975): 228-231. doi:10.1126/science.1179721.
Wei M, Huang F, Zhao L, Zhang Y, Yang W, Wang S, et al. (2020) A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility. EBioMedicine. 55 102766. doi:10.1016/j.ebiom.2020.102766.
Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Mannerås-Holm L, et al. (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 23 (7): 850-858. doi:10.1038/nm.4345.
Xia Y, Su Y, Wang Q, Yang C, Tang B, Zhang Y, et al. (2019) Preparation, characterization, and pharmacodynamics of insulin-loaded fumaryl diketopiperazine microparticle dry powder inhalation. Drug Deliv. 26 (1): 650-660. doi:10.1080/10717544.2019.1631408.
Yang Y, Gong XB, Huang LG, Wang ZX, Wan RZ, Zhang P, et al. (2017) Diosmetin exerts anti-oxidative, anti-inflammatory and anti-apoptotic effects to protect against endotoxin-induced acute hepatic failure in mice. Oncotarget. 8 (19): 30723-30733. doi:10.18632/oncotarget.15413.
Zheng J, Yuan X, Cheng G, Jiao S, Feng C, Zhao X, et al. (2018) Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice. Carbohydr Polym. 190 77-86. doi:10.1016/j.carbpol.2018.02.058.